Mail

Canada markets closed

S&P/TSX
22,308.93
-66.90(-0.30%)
S&P 500
5,222.68
+8.60(+0.16%)
DOW
39,512.84
+125.08(+0.32%)
CAD/USD
0.7315
+0.0004(+0.06%)
CRUDE OIL
78.20
-1.06(-1.34%)
Bitcoin CAD
83,397.63
-3,064.64(-3.54%)

MARKETS LIVE BLOG

STOCKS CLIMB AS DOW POSTS 8TH STRAIGHT WIN

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

Knight Therapeutics Inc. (GUD.TO)

Toronto - Toronto Real Time Price. Currency in CAD

Add to watchlist

5.94

-0.16

(-2.62%)

At close: 04:00PM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	602.17M
Enterprise Value	480.01M
Trailing P/E	N/A
Forward P/E	99.01
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	1.88
Price/Book (mrq)	0.79
Enterprise Value/Revenue	1.69
Enterprise Value/EBITDA	14.32

Trading Information

Stock Price History

Beta (5Y Monthly)	0.46
52-Week Change ³	22.73%
S&P500 52-Week Change ³	26.27%
52 Week High ³	6.17
52 Week Low ³	4.35
50-Day Moving Average ³	5.58
200-Day Moving Average ³	5.14

Share Statistics

Avg Vol (3 month) ³	67.63k
Avg Vol (10 day) ³	56.09k
Shares Outstanding ⁵	101.38M
Implied Shares Outstanding ⁶	101.38M
Float ⁸	52.06M
% Held by Insiders ¹	46.44%
% Held by Institutions ¹	13.68%
Shares Short (Apr 30, 2024) ⁴	3.19M
Short Ratio (Apr 30, 2024) ⁴	57.73
Short % of Float (Apr 30, 2024) ⁴	N/A
Short % of Shares Outstanding (Apr 30, 2024) ⁴	3.12%
Shares Short (prior month Mar 28, 2024) ⁴	3.21M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Dec 31, 2023

Profitability

Profit Margin	-5.13%
Operating Margin (ttm)	-0.11%

Management Effectiveness

Return on Assets (ttm)	0.40%
Return on Equity (ttm)	-2.14%

Income Statement

Revenue (ttm)	328.2M
Revenue Per Share (ttm)	3.05
Quarterly Revenue Growth (yoy)	-9.10%
Gross Profit (ttm)	N/A
EBITDA	53.26M
Net Income Avi to Common (ttm)	-16.84M
Diluted EPS (ttm)	-0.16
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	169.87M
Total Cash Per Share (mrq)	1.68
Total Debt (mrq)	69.09M
Total Debt/Equity (mrq)	9.25%
Current Ratio (mrq)	3.20
Book Value Per Share (mrq)	7.38

Cash Flow Statement

Operating Cash Flow (ttm)	35.94M
Levered Free Cash Flow (ttm)	27.2M